Here are relevant reports on : hematology-reagents-market
-
Cell Counting Market by Product (Instruments (Spectrophotometer, Flow Cytometer, Hematology Analyzers, Cell Counters), Consumables (Media, Reagents, Assays, Microplate)), Application, End User (Pharma & Biotech) - Global Forecast to 2029
The global Cell Counting Market, valued at US$10.82 billion in 2023, grew to US$11.12 billion in 2024 and is projected to reach US$11.83 billion in 2025. The market is expected to advance at a robust CAGR of 7.7% from 2024 to 2029, reaching an estimated US$16.14 billion by 2029. Increasing awareness and adoption of automated and fluorescence-based cell counters, along with declining costs, are driving broader market penetration across research laboratories, clinical diagnostics, and biopharmaceutical applications.
- Published: February 2025
- Price: $ 4950
- TOC Available:
-
Research Antibodies & Reagents Market by Product (Antibodies (Type, Form, Source, Research Area), Reagents), Technology (Western blot, Flow Cytometry, ELISA), Application (Proteomics, Genomics), End User (Pharma, Biotech, CROs) & Region - Global forecast to 2028
The global research antibodies & reagents market, valued at US$1.3 billion in 2022, stood at US$1.8 billion in 2023 and is projected to advance at a resilient CAGR of 45.6% from 2023 to 2028, culminating in a forecasted valuation of US$12.1 billion by the end of the period. The growth of this market is largely driven by an increase in research activity—especially in the life sciences industry—along with growing industry-academia collaborations are a primary growth driver for this market.
- Published: October 2023
- Price: $ 4950
- TOC Available:
-
Antibody Reagents Market - Analysis & Global Forecast to 2020
An antibody reagent is an antibody which is applied as a probe in an experimental technique to identify a specific molecular target of interest, with the goal of detection, isolation, and modulation of this target. These reagents are bioengineered through antibody production process to recognize a specific molecular antigen of interest, or a large target containing unspecified antigen.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Life Sciences & Analytical Reagents Market - Applications, Current Trends, Opportunities & Global Forecasts (2011 – 2016)
The life sciences and analytical reagents market report studies the life science and analytical reagents market, by technology, end-users, and applications. The life sciences and analytical reagents market, by technology studied in this report are segmented as life science reagents and analytical reagents; of which life science segment accounted for the largest share of 59.37% of the total market in 2011.
- Published: May 2012
- Price: $ 4950
- TOC Available:
-
Clinical Laboratory Services Market by Specialty (Biochemistry, Endocrinology, Microbiology, Hematology, Cytology, Histopathology, Genetic Testing), Providers (Independent Laboratory, Reference Laboratory, Hospital Laboratory) & Geography - Global Forecast to 2022
The clinical laboratory services market is expected to reach USD 146.41 billion by 2022 from USD 113.4 billion in 2017, at a CAGR of 5.2% during the forecast period. The major players in the market are Mayo Medical Laboratories (US), Laboratory Corporation of America Holdings (US), Quest Diagnostics Incorporated (US), Spectra Laboratories Inc. (US), DaVita Healthcare Partners (US), Eurofins Scientific (Luxembourg), Unilabs (Switzerland), SYNLAB International (Germany), Bio-Reference Laboratories (US), Sonic Healthcare (UK), Cerba HealthCare (France), and among others
- Published: December 2017
- Price: $ 4950
- TOC Available:
-
In Vitro Diagnostics Market by Product & Service (Kits, Instruments), Technology (Immunoassay, Hematology, Glucose Monitoring), Specimen (Blood), Site of Testing, Application (Endocrinology, Cardiology, Infectious Diseases) & Region- Global Forecast to 2030
The global in vitro diagnostics market, valued at US$101,058.9M in 2024, is forecasted to grow at a 7.6% CAGR, reaching US$109,065.5M by 2025 and US$157,632.5M by 2030. The high growth rate of the Asia Pacific is attributed to the rising prevalence of chronic and infectious diseases across China, India, and Southeast Asian countries, as well as increased healthcare spending and improved access to diagnostic services, particularly in emerging economies.
- Published: May 2025
- Price: $ 4950
- TOC Available:
-
Europe In Vitro Diagnostics Market by Product & Service (Kits, Instruments), Technology (Immunoassay, Hematology, Glucose Monitoring), Specimen (Blood), Site of Testing, Application (Endocrinology, Cardiology, Infectious Diseases) - Forecast to 2031
The Europe in vitro diagnostics market is expected to grow from USD 33.83 billion in 2026 to USD 49.49 billion by 2031, at a compound annual growth rate (CAGR) of 7.9% during the forecast period. The Key Players F. Hoffmann-La Roche Ltd (Switzerland), Abbott (US), Siemens Healthineers AG (Germany), Danaher Corporation (US), Thermo Fisher Scientific Inc. (US), bioMérieux (France), Sysmex Corporation (Japan), Becton, Dickinson and Company (US), Werfen (Spain), and Illumina, Inc. (US).
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
COVID 19 Impact on IVD (In Vitro Diagnostics) Market by Technology (PCR, NGS, ELISA, Rapid Test, Hematology, Hemostasis, Clinical Chemistry, Microbiology Testing, Urinalysis), End-user and Region - Global Forecast to 2025
The COVID 19 Impact on IVD (In Vitro Diagnostics) Market is expected to grow from USD 61.7 billion in 2020 to USD 77.9 billion by 2025, at a CAGR of 4.8% during the forecast period. As of 2019, some of the prominent players in the in-vitro diagnostics market are Roche Diagnostics (Switzerland), Abbott Laboratories (US), Thermo Fisher Scientific (US), Becton, Dickinson and Company (US), Bio-Rad Laboratories (US), Biomerieux (France), and QIAGEN (Germany), among others.
- Published: May 2020
- Price: $ 4950
- TOC Available:
-
US In Vitro Diagnostics Market by Product & Service (Kits, Instruments), Technology (Immunoassay, Hematology, Glucose Monitoring), Specimen (Blood), Site of Testing, Application (Endocrinology, Cardiology, Infectious Diseases) - Forecast to 2031
US In Vitro Diagnostics market, valued at US$37.43 billion in 2025, stood at US$40.15 billion in 2026 and is projected to advance at a resilient CAGR of 7.3% from 2025 to 2031, culminating in a forecasted valuation of US$57.18 billion by the end of the period. This growth is primarily driven by the rising prevalence of chronic and infectious diseases, the increasing demand for early and accurate diagnostic testing, the widespread adoption of advanced molecular diagnostic technologies, the growth in point-of-care testing, and continuous innovations in diagnostic instruments and assays.
- Published: December 2025
- Price: $ 4950
- TOC Available:
-
Plasma Fractionation Market by Product (Immunoglobulins, Albumin, Protease Inhibitors, von Willebrand Factor, PCC), Application (Neurology, Immunology, Hematology, Rheumatology), End User (Clinical Research, Hospitals & Clinics) - Global Forecast to 2028
The global plasma fractionation market, valued at US$27.2 billion in 2022, stood at US$29.0 billion in 2023 and is projected to advance at a resilient CAGR of 6.9% from 2025 to 2028, culminating in a forecasted valuation of US$40.4 billion by the end of the period. Market growth is driven mainly by factors such as the growing use of immunoglobulins in various therapeutic areas, strategic expansion of plasma collection centers/inventories by market players, and the growing prevalence of respiratory diseases and AATD
- Published: September 2023
- Price: $ 4950
- TOC Available:
Records 1 to 10 of 50
